NASDAQ:XTLB

XTL Biopharmaceuticals Stock in Focus Following Nasdaq Delisting Deadline
····

XTL Biopharmaceuticals Stock in Focus Following Nasdaq Delisting Deadline

XTL Biopharmaceuticals shares rose 2.5% to $2.44 Wednesday as investors watched for a Nasdaq panel decision on the company’s U.S. listing. XTL faces delisting after missing its 2025 annual report deadline and failing to meet equity and price rules. The company must request a stay by May 26 and aims to close a Psyga Bio deal and financing plan by June 30 to keep its listing. Investors vote on the Psyga deal June 22.
May 27, 2026

Stock Market Today

  • 2 ASX Dividend Shares for Reliable Passive Income: Telstra and Woolworths
    May 27, 2026, 6:24 PM EDT. Dividend investing requires more than chasing high yields; sustainability matters. Telstra (ASX: TLS) offers a defensive income play with its essential telecommunications services and strong mobile network, despite growth and regulatory risks. Woolworths (ASX: WOW), a supermarket giant, benefits from steady demand for groceries and essentials, backed by scale and trusted brand. Both companies provide franked dividends and resilience through economic cycles, making them reliable choices for investors seeking stable, passive income on the ASX.